Ken Bridges

Ken Bridges is an experienced executive in the pharmaceutical and biotechnology sectors, currently serving as Vice President at Global Blood Therapeutics since September 2015. With a history of retired status at Pfizer from July 2023 to January 2024, Ken has held various key positions including Executive Director at Amgen and Senior Medical Director at Onyx Pharmaceuticals, where oversight of clinical research protocols was a primary focus. Ken's earlier roles include Medical Director at Amgen and Clinical Scientist at Roche Pharmaceuticals, specializing in the development of clinical research protocols. From 1982 to 2005, Ken was an Associate Professor of Medicine at Brigham and Women's Hospital and Harvard Medical School, concentrating on iron metabolism and hemoglobinopathies. Ken holds an MD from Harvard Medical School and a Bachelor of Arts in Zoology from the University of Michigan.